Published on 26 Oct 2023 on Zacks via Yahoo Finance
Amedisys, Inc. AMED reported adjusted earnings per share (EPS) of $98 cents in the third quarter of 2023, down 14.8% from the year-ago quarter’s figure. The bottom line missed the Zacks Consensus Estimate by 9.3%.
The quarter’s adjustments include certain acquisition and integration costs, clinical optimization and reorganization costs and executive board of directors/CEO transition awards.
GAAP loss per share in the third quarter was 79 cents, in line with the year-ago GAAP EPS of 79 cents.